Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

United States

Arthrosi Investigative Site (105), Margate, Florida

Arthrosi Investigative Site (102), Miami, Florida

Arthrosi Investigative Site (109), Tampa, Florida

Arthrosi Investigative Site (106), Jackson, Mississippi

Arthrosi Investigative Site (108), Charlotte, North Carolina

Arthrosi Investigative Site (103), Duncansville, Pennsylvania

Arthrosi Investigative Site (104), West Lake Hills, Texas

Arthrosi Investigative Site (107), Bellevue, Washington